2024-10-19 - Analysis Report
## Mondelez International Inc. (MDLZ) Stock Analysis:

**1. Performance & Relative Performance:**

Mondelez International Inc. (MDLZ) is a multinational food and beverage company that manufactures and markets a variety of snacks, beverages, and other food products. 

The cumulative return of MDLZ is **65.03%**, while the cumulative return of the S&P 500 (VOO) is **137.88%**. This represents a **-72.85%** difference in performance, placing MDLZ at the **7.64th** percentile of its historical relative performance against the S&P 500. 

**2. Recent Price Movements:**

* **Closing Price:** $71.58
* **5-day Moving Average:** $71.39
* **20-day Moving Average:** $72.25
* **60-day Moving Average:** $71.84

This indicates that MDLZ is currently trading below its 20-day and 60-day moving averages but above its 5-day moving average.  

**3. Technical Indicators & Sentiment:**

* **RSI:** 34.79 - This suggests that MDLZ is currently in oversold territory, potentially indicating a bounce in the near term.
* **PPO:** -0.13 - This indicates a negative momentum for MDLZ, suggesting further downward pressure.
* **Delta_Previous_Relative_Divergence:** -11.05 - The negative value indicates a recent downward trend in relative price performance compared to the S&P 500.
* **Expected_Return:** 0.0% - This indicates that MDLZ is not expected to outperform the S&P 500 significantly in the long term.

**4. Recent Earnings & Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-30 | 0.45 | 8.34 B$ |
| 2024-04-30 | 1.05 | 9.29 B$ |
| 2023-11-01 | 0.72 | 9.03 B$ |
| 2023-07-27 | 0.69 | 8.51 B$ |
| 2024-07-30 | 0.69 | 8.51 B$ |

The most recent earnings report (2024-07-30) revealed that MDLZ beat revenue estimates but missed EPS expectations. While revenue growth is encouraging, the missed EPS target suggests challenges in profitability. 

**5. News & Recent Issues:**

According to FINBOLD, recent market sentiment surrounding MDLZ is **mixed**. 

**Analyst Opinions:**

* **Morgan Stanley:** Outperform
* **Goldman Sachs:** Buy
* **JPMorgan Chase:** Neutral

**Performance Highlights:**

* MDLZ has been experiencing strong organic revenue growth, driven by price increases and volume growth.
* The company is facing headwinds from rising inflation and supply chain disruptions. 
* MDLZ is actively pursuing cost-cutting measures to improve profitability.

**6. Summary & Conclusion:**

MDLZ currently faces challenges in terms of relative performance against the S&P 500, with a significant underperformance. The company is experiencing mixed sentiment in the market, with some analysts optimistic about its long-term growth potential. The recent earnings report reflects a strong revenue performance but missed EPS expectations, suggesting challenges in profitability. 

**7. Recommendations:**

Based on the current analysis, MDLZ appears to be a **high-risk, high-reward** investment. The oversold RSI suggests a potential bounce in the near term, but the negative PPO and recent relative performance trends point to potential further downward pressure. While the company is pursuing growth strategies, navigating inflationary pressures and achieving sustainable profitability remains a key challenge. Investors should carefully consider their risk tolerance before investing in MDLZ. 
